Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New Endoscopic Approach Relieves Gastroparesis Symptoms

By HospiMedica International staff writers
Posted on 24 Sep 2018
Per-oral pyloromyotomy (POP), an endoscopic intramural treatment for gastroparesis, significantly improves patient symptoms and gastric emptying, according to a new study.

Researchers at the Cleveland Clinic (CC; OH, USA) and Case Western Reserve University (CWRU; Cleveland, OH, USA) conducted a retrospective study to compare all 30 patients who underwent laparoscopic pyloroplasty (LP) for treatment of gastroparesis with those undergoing POP from October 2014 through September 2017. More...
Patients were matched on a 1:1 basis, based on gender, age, and etiology of gastroparesis, which was 63.3% idiopathic, 20.0% post-surgical, and 16.7% diabetic (in both cohorts).

The results revealed that patients who underwent LP had an almost triple average length of stay and estimated blood loss than those that underwent POP. There were more overall complications in the LP cohort than in the POP one (16.7 versus. 3.3%, respectively), including surgical site infection (6.7 versus 0%), pneumonia (6.7% versus 0%), and unplanned ICU admission (10% versus 0%). LP and POP both resulted in similar, significant improvements in both in gastroparesis cardinal symptom index (GCSI) scores and objective gastric emptying. The study was published on July 17, 2018, in Surgical Endoscopy.

“When you compare the results in terms of symptom improvement and the complication rate of this as a new procedure, we’re doing much better than every other option that we have for patients with gastroparesis,” said senior author John Rodriguez, MD, director of surgical endoscopy at the Cleveland Clinic. “The procedure is very safe, and there were no procedure-related adverse events, including gastric or duodenal ulcer, intraluminal hemorrhage, or gastric dumping syndrome.”

Gastroparesis, a delayed gastric emptying in the absence of mechanical obstruction, is a debilitating and chronic digestive disease affecting five million people in the U.S. alone. Surgical options are few: gastric electrical stimulation, gastric emptying procedures, gastric diversion or gastric resection. POP is a less invasive method of disrupting the pylorus; the technique involves an initial mucosotomy to create a submucosal tunnel up to the duodenal bulb, followed by a myotomy of the circular fibers of the pylorus. The mucosotomy is subsequently closed with clips.

Related Links:
Cleveland Clinic
Case Western Reserve University


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.